On September 29th, Nephron hosted one of the top thought leaders in the industry, Dr. Howard Levine, for a discussion on implications of COVID-19 drug development on bioprocessing. Topics of discussion included sizing the market opportunity for COVID-19 treatments and vaccines for the industry, as well as a closer look at the technologies and providers who will be supporting the scale-up of vaccines and therapeutics related to the disease.